Halama, Niels
Article History
Received: 16 September 2018
Revised: 15 October 2018
Accepted: 19 October 2018
First Online: 9 November 2018
Competing interests
: The author declares the following possible conflict of interest: intellectual property for CCR5 inhibition in anticancer treatment owned by academic institution.